Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Q3 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
Q1 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
AEON Biopharma, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. AEON Biopharma, Inc. has generated $0 earnings per share over the last year ($0 diluted earnings per share) and currently has a price-to-earnings ratio of 0.91. AEON Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/30/2024 | Q3 2024 | $0.00 | $0 | $0 | ||
06/29/2024 | Q2 2024 | $4.22 | $0 | $0 | ||
03/30/2024 | Q1 2024 | -$3.17 | $0 | |||
06/29/2023 | Q2 2023 | -$0.56 | $0 | |||
03/30/2023 | Q1 2023 | -$0.80 | $0 | |||
12/30/2022 | Q4 2022 | $0.00 | $0 | |||
09/29/2022 | Q3 2022 | -$0.47 | $0 |
AEON Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
In the previous quarter, AEON Biopharma, Inc. (:AEON) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.03.
The conference call for AEON Biopharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for AEON Biopharma, Inc.'s latest earnings report can be read online.
AEON Biopharma, Inc. (:AEON) has a recorded net income of $0. AEON Biopharma, Inc. has generated $0 earnings per share over the last four quarters.
AEON Biopharma, Inc. (:AEON) has a price-to-earnings ratio of 0.91 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED